Synonyms: | |
Status: | Phase 2 |
Entry Type: | Small molecule |
Molecule Category: | UNKNOWN |
UNII: | H0C805XYDE |
InChI Key | GPKJTRJOBQGKQK-UHFFFAOYSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C23H30ClN3O |
Molecular Weight | 399.97 |
AlogP | 5.97 |
Hydrogen Bond Acceptor | 4.0 |
Hydrogen Bond Donor | 1.0 |
Number of Rotational Bond | 9.0 |
Polar Surface Area | 37.39 |
Molecular species | BASE |
Aromatic Rings | 3.0 |
Heavy Atoms | 28.0 |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Enzyme
Hydrolase
|
- | 100000 | - | - | 15 | |
Enzyme
Oxidoreductase
|
- | 10000 | - | 19000-19000 | - | |
Enzyme
Transferase
|
- | 20000 | - | - | 50-82 | |
Ion channel
Voltage-gated ion channel
Voltage-gated calcium channel
|
- | 5200 | - | - | - | |
Ion channel
Voltage-gated ion channel
Voltage-gated sodium channel
|
- | 3300 | - | - | 73 | |
Surface antigen
|
300 | - | - | - | - | |
Transcription factor
Nuclear receptor
Nuclear hormone receptor subfamily 3
Nuclear hormone receptor subfamily 3 group C
Nuclear hormone receptor subfamily 3 group C member 4
|
- | - | - | - | 72 | |
Unclassified protein
|
- | - | 264 | 6700 | - |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Carcinoma, Renal Cell | 2 | D002292 | ClinicalTrials |
Creutzfeldt-Jakob Syndrome | 2 | D007562 | ClinicalTrials |
Prostatic Neoplasms, Castration-Resistant | 2 | D064129 | ClinicalTrials |
Colorectal Neoplasms | 1 | D015179 | ClinicalTrials |
Carcinoma, Non-Small-Cell Lung | 1 | D002289 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 83-89-6 |
ChEBI | 8711 |
ChEMBL | CHEMBL7568 |
DrugBank | DB01103 |
DrugCentral | 2338 |
EPA CompTox | DTXSID7022627 |
FDA SRS | H0C805XYDE |
Human Metabolome Database | HMDB0015235 |
Guide to Pharmacology | 10172 |
KEGG | C07339 |
PharmGKB | PA164745551 |
PubChem | 237 |
SureChEMBL | SCHEMBL19225 |